Allarity Therapeutics, Inc. (ALLR) Financials
ALLR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 11.9 million | 14.6 million |
| 2023-09-30 | 13.9 million | 17.3 million |
| 2023-06-30 | 13.4 million | 14.1 million |
| 2023-03-31 | 12.7 million | 13.0 million |
ALLR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -1.7 million | -254000 |
| 2023-09-30 | -5.4 million | 124000 |
| 2023-06-30 | -2.5 million | 180000 |
| 2023-03-31 | -3.2 million | -121000 |
ALLR Net Income
No data available :(
ALLR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 166000 | - | - |
| 2023-09-30 | 1.4 million | - | - |
| 2023-06-30 | 420000 | - | - |
| 2023-03-31 | 295000 | - | - |
ALLR Shares Outstanding
ALLR Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | 2.6 million | 2.3 million | - |
| 2023-09-30 | - | 1.9 million | 2.5 million | - |
| 2023-06-30 | - | 1.1 million | 3.1 million | - |
| 2023-03-31 | - | 1.4 million | 2.2 million | - |
ALLR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | 9000 |
| 2023-09-30 | - | 18000 |
| 2023-06-30 | - | 18000 |
| 2023-03-31 | - | 20000 |
ALLR
Price: $1
52 week price:
Earnings Per Share: -205.20 USD
P/E Ratio: 0.00
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 959260
Market Capitalization: 942348